【Group overview】
Baird Medical Group (Baird Medical, listed on the Nasdaq market on October 2, 2024, the stock code BDMD) and its subsidiaries, is a medical device company in China engaged in the research, development, manufacture, and sale of microwave ablation devices for the treatment of benign and malignant tumors with increasing incidence.
The company, with its internationally advanced and fully-owned intellectual property rights in tumor microwave ablation treatment, is committed to becoming a provider of comprehensive solutions in the field of tumor treatment and a leader in precision medicine for clinical pathways of single diseases.